Crohn ’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors
ConclusionsWe describe a dissimilarity of ileal microbiota composition comparing CD and healthy settings, as well as systemic microbial-associated inflammatory factors between first surgery and surgical relapse. We suggest that patterns of microbiota, associated with healthy ileal tissue, could be involved in triggering CD recurrence. Our findings may provide insight into the dynamics of the gut microbiota–immunity axis in CD surgical recurrence, paving the way for new diagnostics and therapeutics aimed not only at reducing inflammation but also at maintaining a general state of eubiosis in healthy tissue. (Source: Frontiers in Immunology)
Source: Frontiers in Immunology - July 29, 2022 Category: Allergy & Immunology Source Type: research

EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn's disease treated with immunomodulator
Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):739-741. doi: 10.4103/IJPM.IJPM_1099_20.NO ABSTRACTPMID:35900522 | DOI:10.4103/IJPM.IJPM_1099_20 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: Nivedita Patnaik Sunil Pasricha Gurudutt Gupta Garima Durga Sanjeev K Sharma Anila Sharma Meenakshi Kamboj Varun Goel Ankush Jajodia Anurag Mehta Source Type: research

Role of Immunohistochemistry and serology in subclassifying the Inflammatory Bowel Disease cases diagnosed as Inflammatory Bowel Diseases---unclassified on colonic biopsies
CONCLUSION: The two major tools IHC for β-catenin and RB protein and the assay of serum ASCA and p-ANCA along with proper history and clinical presentation can act as a good adjunct to conventional H and E in subclassifying cases of IBD-U into UC and CD.PMID:35900482 | DOI:10.4103/ijpm.ijpm_739_21 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: None Paridhi Kuldeep Singh Varsha Kumar Shatakshee Tewari Vatsala Misra Sri Prakash Misra Manisha Dwivedi Source Type: research

Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Korean J Intern Med. 2022 Jul 29. doi: 10.3904/kjim.2022.138. Online ahead of print.ABSTRACTInflammatory bowel disease (IBD) refers to a group of disorders, including Crohn's disease and ulcerative colitis, that exhibit similar but distinct manifestations. These diseases are characterized by refractory and chronic inflammation of the bowel. IBD is usually accompanied by severe symptoms. When a patient presents with suspected IBD, physicians encounter various challenges in terms of diagnosis and treatment. In addition, given such characteristics, the associated medical expenses gradually increase. Although IBD was formerly ...
Source: The Korean Journal of Internal Medicine - July 28, 2022 Category: Internal Medicine Authors: Jung Won Lee Chang Soo Eun Source Type: research

EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn's disease treated with immunomodulator
Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):739-741. doi: 10.4103/IJPM.IJPM_1099_20.NO ABSTRACTPMID:35900522 | DOI:10.4103/IJPM.IJPM_1099_20 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: Nivedita Patnaik Sunil Pasricha Gurudutt Gupta Garima Durga Sanjeev K Sharma Anila Sharma Meenakshi Kamboj Varun Goel Ankush Jajodia Anurag Mehta Source Type: research

Role of Immunohistochemistry and serology in subclassifying the Inflammatory Bowel Disease cases diagnosed as Inflammatory Bowel Diseases---unclassified on colonic biopsies
CONCLUSION: The two major tools IHC for β-catenin and RB protein and the assay of serum ASCA and p-ANCA along with proper history and clinical presentation can act as a good adjunct to conventional H and E in subclassifying cases of IBD-U into UC and CD.PMID:35900482 | DOI:10.4103/ijpm.ijpm_739_21 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: None Paridhi Kuldeep Singh Varsha Kumar Shatakshee Tewari Vatsala Misra Sri Prakash Misra Manisha Dwivedi Source Type: research

Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Korean J Intern Med. 2022 Jul 29. doi: 10.3904/kjim.2022.138. Online ahead of print.ABSTRACTInflammatory bowel disease (IBD) refers to a group of disorders, including Crohn's disease and ulcerative colitis, that exhibit similar but distinct manifestations. These diseases are characterized by refractory and chronic inflammation of the bowel. IBD is usually accompanied by severe symptoms. When a patient presents with suspected IBD, physicians encounter various challenges in terms of diagnosis and treatment. In addition, given such characteristics, the associated medical expenses gradually increase. Although IBD was formerly ...
Source: The Korean Journal of Internal Medicine - July 28, 2022 Category: Internal Medicine Authors: Jung Won Lee Chang Soo Eun Source Type: research

EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn's disease treated with immunomodulator
Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):739-741. doi: 10.4103/IJPM.IJPM_1099_20.NO ABSTRACTPMID:35900522 | DOI:10.4103/IJPM.IJPM_1099_20 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: Nivedita Patnaik Sunil Pasricha Gurudutt Gupta Garima Durga Sanjeev K Sharma Anila Sharma Meenakshi Kamboj Varun Goel Ankush Jajodia Anurag Mehta Source Type: research

Role of Immunohistochemistry and serology in subclassifying the Inflammatory Bowel Disease cases diagnosed as Inflammatory Bowel Diseases---unclassified on colonic biopsies
CONCLUSION: The two major tools IHC for β-catenin and RB protein and the assay of serum ASCA and p-ANCA along with proper history and clinical presentation can act as a good adjunct to conventional H and E in subclassifying cases of IBD-U into UC and CD.PMID:35900482 | DOI:10.4103/ijpm.ijpm_739_21 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: None Paridhi Kuldeep Singh Varsha Kumar Shatakshee Tewari Vatsala Misra Sri Prakash Misra Manisha Dwivedi Source Type: research

Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Korean J Intern Med. 2022 Jul 29. doi: 10.3904/kjim.2022.138. Online ahead of print.ABSTRACTInflammatory bowel disease (IBD) refers to a group of disorders, including Crohn's disease and ulcerative colitis, that exhibit similar but distinct manifestations. These diseases are characterized by refractory and chronic inflammation of the bowel. IBD is usually accompanied by severe symptoms. When a patient presents with suspected IBD, physicians encounter various challenges in terms of diagnosis and treatment. In addition, given such characteristics, the associated medical expenses gradually increase. Although IBD was formerly ...
Source: The Korean Journal of Internal Medicine - July 28, 2022 Category: Internal Medicine Authors: Jung Won Lee Chang Soo Eun Source Type: research

EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn's disease treated with immunomodulator
Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):739-741. doi: 10.4103/IJPM.IJPM_1099_20.NO ABSTRACTPMID:35900522 | DOI:10.4103/IJPM.IJPM_1099_20 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: Nivedita Patnaik Sunil Pasricha Gurudutt Gupta Garima Durga Sanjeev K Sharma Anila Sharma Meenakshi Kamboj Varun Goel Ankush Jajodia Anurag Mehta Source Type: research

Role of Immunohistochemistry and serology in subclassifying the Inflammatory Bowel Disease cases diagnosed as Inflammatory Bowel Diseases---unclassified on colonic biopsies
CONCLUSION: The two major tools IHC for β-catenin and RB protein and the assay of serum ASCA and p-ANCA along with proper history and clinical presentation can act as a good adjunct to conventional H and E in subclassifying cases of IBD-U into UC and CD.PMID:35900482 | DOI:10.4103/ijpm.ijpm_739_21 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: None Paridhi Kuldeep Singh Varsha Kumar Shatakshee Tewari Vatsala Misra Sri Prakash Misra Manisha Dwivedi Source Type: research

Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Korean J Intern Med. 2022 Jul 29. doi: 10.3904/kjim.2022.138. Online ahead of print.ABSTRACTInflammatory bowel disease (IBD) refers to a group of disorders, including Crohn's disease and ulcerative colitis, that exhibit similar but distinct manifestations. These diseases are characterized by refractory and chronic inflammation of the bowel. IBD is usually accompanied by severe symptoms. When a patient presents with suspected IBD, physicians encounter various challenges in terms of diagnosis and treatment. In addition, given such characteristics, the associated medical expenses gradually increase. Although IBD was formerly ...
Source: The Korean Journal of Internal Medicine - July 28, 2022 Category: Internal Medicine Authors: Jung Won Lee Chang Soo Eun Source Type: research

EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn's disease treated with immunomodulator
Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):739-741. doi: 10.4103/IJPM.IJPM_1099_20.NO ABSTRACTPMID:35900522 | DOI:10.4103/IJPM.IJPM_1099_20 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: Nivedita Patnaik Sunil Pasricha Gurudutt Gupta Garima Durga Sanjeev K Sharma Anila Sharma Meenakshi Kamboj Varun Goel Ankush Jajodia Anurag Mehta Source Type: research

Role of Immunohistochemistry and serology in subclassifying the Inflammatory Bowel Disease cases diagnosed as Inflammatory Bowel Diseases---unclassified on colonic biopsies
CONCLUSION: The two major tools IHC for β-catenin and RB protein and the assay of serum ASCA and p-ANCA along with proper history and clinical presentation can act as a good adjunct to conventional H and E in subclassifying cases of IBD-U into UC and CD.PMID:35900482 | DOI:10.4103/ijpm.ijpm_739_21 (Source: Indian Journal of Pathology and Microbiology)
Source: Indian Journal of Pathology and Microbiology - July 28, 2022 Category: Pathology Authors: None Paridhi Kuldeep Singh Varsha Kumar Shatakshee Tewari Vatsala Misra Sri Prakash Misra Manisha Dwivedi Source Type: research